A Gastrointestinal Test to Detect Endocrine Pancreatic Insufficiency
The BÜHLMANN fPELA® turbo is a test for the quantitative determination of pancreatic elastase in human fecal extracts and is intended to be run on clinical chemistry analyzers.
This test is a particle enhanced turbidimetric immunoassay (PETIA) assay developed to be run directly with stool extracts derived from the CALEX® Cap extraction device. This device is pre-filled with unique extraction buffer designed for fecal extraction of pancreatic elastase and calprotectin, allowing for quantification of both analytes at the same time.
Fecal pancreatic elastase is a well-established biomarker to detect exocrine pancreatic insufficiency in patients suffering from conditions such as chronic pancreatitis and cystic fibrosis. The concentration of pancreatic elastase levels in feces reflects the level of pancreatic output and correlates with the output of other pancreatic enzymes such as lipase, amylase, and trypsin.
Speed, Quality, Flexibility
This assay is a non-invasive, sensitive and specific assay that is unique in speed, quality, and flexibility. This offers accurate results and reliable information to aid clinicians in selecting patients for further diagnostic procedures.
fast pancreatic test, time-to-first-result within 10 minutes
high correlation to the manual gold standard reference method, specific to human enzymatic isoforms, and uses highly precise and reproducible PETIA technology
can be applied on most open chemistry platforms (in the same fecal extract used for calprotectin testing) streamlining your workflow using random access automation